Evidence map›Paper›PMID 38987305›Full record

ArticleScientific reports2024

Portable and affordable cold air plasma source with optimized bactericidal effect.

Myron Klenivskyi, Josef Khun, Laura Thonová, Eva Vaňková, Vladimír Scholtz

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Myron KlenivskyiDepartment of Physics and Measurements, University of Chemistry and Technology, Prague, Czech Republic.
Josef KhunDepartment of Physics and Measurements, University of Chemistry and Technology, Prague, Czech Republic.
Laura ThonováDepartment of Physics and Measurements, University of Chemistry and Technology, Prague, Czech Republic.
Eva VaňkováDepartment of Physics and Measurements, University of Chemistry and Technology, Prague, Czech Republic.
Vladimír ScholtzDepartment of Physics and Measurements, University of Chemistry and Technology, Prague, Czech Republic. scholtzv@vscht.cz.

Funding

Grantová Agentura České Republiky 21-39019L
6 · The paper itself

Abstract

The paper reports a low-cost handheld source of a cold air plasma intended for biomedical applications that can be made by anyone (detailed technical information and a step-by-step guide for creating the NTP source are provided). The plasma source employs a 1.4 W corona discharge in the needle-to-cone electrode configuration and is an extremely simple device, consisting basically of two electrodes and a cheap power supply. To achieve the best bactericidal effect, the plasma source has been optimized on Escherichia coli. The bactericidal ability of the plasma source was further tested on a wide range of microorganisms: Staphylococcus aureus as a representative of gram-positive bacteria, Pseudomonas aeruginosa as gram-negative bacteria, Candida albicans as yeasts, Trichophyton interdigitale as microfungi, and Deinococcus radiodurans as a representative of extremophilic bacteria resistant to many DNA-damaging agents, including ultraviolet and ionizing radiation. The testing showed that the plasma source inactivates all the microorganisms tested in several minutes (up to 10

Indexed as

Plasma GasesAnti-Bacterial AgentsCandida albicansEscherichia coliStaphylococcus aureusAnti-Bacterial AgentsPlasma GasesBactericidal effectCold air plasmaCorona dischargeIon windReactive oxygen and nitrogen species

Identifiers

PMID38987305
PMCPMC11237098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.